financetom
NGNE
financetom
/
Healthcare
/
NGNE
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Neurogene Inc.NGNE
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases.

Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease.

The company is headquartered in New York, New York.

Copyright 2023-2025 - www.financetom.com All Rights Reserved